Loading clinical trials...

A Study to Evaluate Ovarian Follicular Activity and Hormone Levels for DR-102 Compared to Two 28-Day Oral Contraceptives | Clinical Trials | Clareo Health

Back to clinical trial search

COMPLETEDPhase 1NCT01291004

A Study to Evaluate Ovarian Follicular Activity and Hormone Levels for DR-102 Compared to Two 28-Day Oral Contraceptives

This study is being conducted to evaluate the impact of a 28-day oral contraceptive compared to two 28-day oral contraceptive regimens containing different synthetic progestins on ovarian follicular a...

Lead sponsor: Teva Branded Pharmaceutical Products R&D, Inc.•2 U.S. locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Related studies

COMPLETEDNA

Mid-luteal Phase Synchronization of Ovarian Folliculogenesis in Women

NCT00565240 · Ovarian Follicle

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: December 8, 2021Terms

Trial snapshot

StatusCOMPLETED

PhasePHASE1

Enrollment206

Start dateJan 2011

Last updatedDec 8, 2021

Condition

Follicle Development Ovarian Follicle Follicle Count Follicle Size Oral Contraceptive

Locations shown

Teva Investigational Site 10119

Philadelphia, Pennsylvania

Teva Investigational Site 10118

Seattle, Washington

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: December 8, 2021Data synced to Clareo: May 25, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions